<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
"http://www.w3.org/TR/REC-html40/loose.dtd"> 
<html>
<head>
<title>Untitled Document</title>
<meta http-equiv="Content-Type" content="text/html;charset=utf-8">
</head>
<body>
<p>

# en/1.xml.gz<br>
# hr/1.xml.gz

<p><hr>
(src)="1"> You may need to read it again . <br>
(trg)="1"> Možda ćete ju trebati ponovo pročitati . <br>
<hr>
(src)="2"> Do not pass it on to others . <br>
(trg)="2"> Nemojte ga davati drugima . <br>
<hr>
(src)="3"> 3 years . <br>
(trg)="3"> 3 godine . <br>
<hr>
(src)="4"> Contains E110 . <br>
(trg)="4"> Sadrži E110 . <br>
<hr>
(src)="5"> However , protein appears to interfere the least . <br>
(trg)="5"> Međutim , čini se da proteini najmanje interferiraju . <br>
<hr>
(src)="6"> DATE OF REVISION OF THE TEXT <br>
(trg)="6"> DATUM REVIZIJE TEKSTA <br>
<hr>
(src)="7"> These measures will help to protect the environment . <br>
(trg)="7"> Ove mjere pomoći će u zaštiti okoliša . <br>
<hr>
(src)="8"> OTHER SPECIAL WARNING ( S ) , IF NECESSARY <br>
(trg)="8"> DRUGA POSEBNA UPOZORENJA ( UKOLIKO JE POTREBNO ) <br>
<hr>
(src)="9"> It may harm them , even if their symptoms are the same as yours . <br>
(trg)="9"> Može im štetiti , čak i ako imaju simptome jednake Vašima . <br>
<hr>
(src)="10"> Always take Wilzin exactly as your doctor has told you . <br>
(trg)="10"> Uvijek uzmite lijek Wilzin točno onako kako Vam je rekao liječnik . <br>
<hr>
(src)="11"> A change of therapy is recommended in this situation . <br>
(trg)="11"> U ovoj se situaciji preporučuje promjena terapije . <br>
<hr>
(src)="12"> The expiry date refers to the last day of that month . <br>
(trg)="12"> Rok valjanosti odnosi se na zadnji dan navedenog mjeseca . <br>
<hr>
(src)="13"> Each bottle contains 250 capsules . <br>
(trg)="13"> Svaka bočica sadrži 250 kapsula . <br>
<hr>
(src)="14"> Not applicable . <br>
(trg)="14"> Nije primjenjivo . <br>
<hr>
(src)="15"> Ask your pharmacist how to dispose of medicines no longer required . <br>
(trg)="15"> Pitajte svog ljekarnika kako ukloniti lijekove koje više ne trebate . <br>
<hr>
(src)="16"> This is to ensure that you receive sufficient treatment . <br>
(trg)="16"> To je iz razloga da se osigura da primate dovoljnu terapiju . <br>
<hr>
(src)="17"> No special requirements <br>
(trg)="17"> Nema posebnih zahtjeva . <br>
<hr>
(src)="18"> • Children and adolescents : <br>
(trg)="18"> • Djeca i adolescenti : <br>
<hr>
(src)="19"> 4.5 Interaction with other medicinal products and other forms of interaction <br>
(trg)="19"> 4.5 Interakcije s drugim lijekovima i drugi oblici interakcija <br>
<hr>
(src)="20"> - This medicine has been prescribed for you personally . <br>
(trg)="20"> - Ovaj je lijek propisan Vama . <br>
<hr>
(src)="21"> This is usually worst with the first morning dose and disappears after the first days of treatment . <br>
(trg)="21"> Ona je obično najgora uz prvu jutarnju dozu i nestaje nakon prvih dana liječenja . <br>
<hr>
(src)="22"> Please consult your doctor if you plan to become pregnant . <br>
(trg)="22"> Molimo Vas da se posavjetujete sa svojim liječnikom ukoliko planirate trudnoću . <br>
<hr>
(src)="23"> There are also links to other websites about rare diseases and treatments . <br>
(trg)="23"> Tamo se također nalaze poveznice na druge web stranice o rijetkim bolestima i liječenjima istih . <br>
<hr>
(src)="24"> You should check with your doctor or pharmacist if you are not sure . <br>
(trg)="24"> Provjerite s Vašim liječnikom ili ljekarnikom ukoliko niste sigurni . <br>
<hr>
(src)="25"> Please tell your doctor or your pharmacist if you are taking or have recently taken any other medicines , including medicines obtained without a prescription . <br>
(trg)="25"> Obavijestite svog liječnika ili ljekarnika ukoliko uzimate ili ste nedavno uzimali bilo koje druge lijekove , uključujući i one koje ste nabavili bez recepta . <br>
<hr>
(src)="26"> Treatment of Wilson 's disease . <br>
(trg)="26"> Liječenje Wilsonove bolesti . <br>
<hr>
(src)="27"> • Risk Management Plan ( RMP ) <br>
(trg)="27"> • Plan upravljanja rizikom ( RMP ) Nije primjenjivo . <br>
<hr>
(src)="28"> 6.2 Incompatibilities <br>
(trg)="28"> 6.2 Inkompatibilnosti <br>
<hr>
(src)="29"> UNIQUE IDENTIFIER - 2D BARCODE <br>
(trg)="29"> 17 . <br>
(trg)="30"> JEDINSTVENI IDENTIFIKATOR - 2D BARKOD <br>
<hr>
(src)="30"> Wilzin is a life-long therapy . <br>
(trg)="31"> Wilzin je doživotna terapija . <br>
<hr>
(src)="31"> Data are very limited in children under 6 years but since the disease is fully penetrant , prophylactic treatment should be considered as early as possible . <br>
(trg)="32"> Podaci su vrlo ograničeni za djecu mlađu od 6 godina , ali s obzirom da je bolest potpuno penetrantna , profilaktičko liječenje treba razmotriti što je ranije moguće . <br>
<hr>
(src)="32"> Read all of this leaflet carefully before you start taking this medicine . <br>
(trg)="33"> Pažljivo pročitajte cijelu uputu prije nego počnete uzimati lijek . <br>
<hr>
(src)="33"> Delaying the first dose to mid-morning or taking the dose with a little protein may usually relieve the symptoms . <br>
(trg)="34"> Odgađanje prve doze do sredine jutra ili uzimanje doze s malo proteina obično mogu ublažiti simptome . <br>
<hr>
(src)="34"> Frequencies are defined as : very common ( ≥ 1 / 10 ) , common ( ≥ 1 / 100 to &lt; 1 / 10 ) , uncommon ( ≥ 1 / 1,000 to &lt; 1 / 100 ) , rare ( ≥ 1 / 10,000 to &lt; 1 / 1,000 ) , very rare ( &lt; 1 / 10,000 ) , not known ( cannot be estimated from the available data ) . <br>
(trg)="35"> Učestalost je definirana prema sljedećim pravilima : vrlo često ( ≥ 1 / 10 ) , često ( ≥ 1 / 100 i &lt; 1 / 10 ) , manje često ( ≥ 1 / 1000 i &lt; 1 / 100 ) , rijetko ( ≥ 1 / 10 000 do &lt; 1 / 1000 ) , vrlo rijetko ( &lt; 1 / 10 000 ) , nepoznato ( ne može se procijeniti na temelju dostupnih podataka ) . <br>
<hr>
(src)="35"> This includes any possible side effects not listed in this leaflet . <br>
(trg)="36"> To uključuje i svaku moguću nuspojavu koja nije navedena u ovoj uputi . <br>
<hr>
(src)="36"> The bottle also contains a cotton filler . <br>
(trg)="37"> Bočica također sadrži umetak od pamučne vate . <br>
<hr>
(src)="37"> If you take more Wilzin than you should : <br>
(trg)="38"> Ako uzmete više Wilzina nego što ste trebali <br>
<hr>
(src)="38"> In this case you must ask your doctor for advice . <br>
(trg)="39"> U ovom slučaju morate pitati svog liječnika za savjet . <br>
<hr>
(src)="39"> Medicines should not be disposed of via wastewater or household waste . <br>
(trg)="40"> Lijekovi se ne smiju uklanjati putem otpadnih voda ili kućnog otpada . <br>
<hr>
(src)="40"> - Keep this leaflet . <br>
(trg)="41"> - Sačuvajte ovu uputu . <br>
<hr>
(src)="41"> The holder of this marketing authorisation must inform the European Commission about the marketing plans for the medicinal product authorised by this decision . <br>
(trg)="42"> Nositelj ovog odobrenja mora obavijestiti Europsku komisiju o marketinškim planovima vezanim za lijek odobren ovom odlukom . <br>
<hr>
(src)="42"> Some patients experience stomach upset after the morning dose . <br>
(trg)="43"> Neki bolesnici osjete želučane smetnje nakon jutarnje doze . <br>
<hr>
(src)="43"> Wilson 's disease will persist during the entire lifetime of the patient and therefore the need for this treatment is life-long . <br>
(trg)="44"> Wilsonova bolest trajat će cijeloga bolesnikova života te je stoga potreba za ovim liječenjem doživotna . <br>
<hr>
(src)="44"> You should tell your doctor if you experience unusual muscle weakness or abnormal feeling in your limbs as this may indicate excessive treatment . <br>
(trg)="45"> Morate reći Vašem liječniku ako osjetite neuobičajenu mišićnu slabost ili nenormalni osjećaj u Vašim ekstremitetima jer to može upućivati na pretjerano liječenje . <br>
<hr>
(src)="45"> Date of latest renewal : 13 October 2009 <br>
(trg)="46"> Datum posljednje obnove : 13 . listopad 2009 . <br>
<hr>
(src)="46"> If you become pregnant during therapy with Wilzin , your doctor will decide which treatment and which dose is best in your situation . <br>
(trg)="47"> Ukoliko ostanete trudni tijekom liječenja Wilzinom , Vaš će liječnik odlučiti koja je terapija i koja doza najbolja u Vašoj situaciji . <br>
<hr>
(src)="47"> Taking other medicines <br>
(trg)="48"> Uzimanje drugih lijekova <br>
<hr>
(src)="48"> FURTHER INFORMATION <br>
(trg)="49"> DODATNE INFORMACIJE <br>
<hr>
(src)="49"> What Wilzin looks like and contents of the pack <br>
(trg)="50"> Kako Wilzin izgleda i sadržaj pakovanja <br>
<hr>
(src)="50"> WHAT WILZIN IS AND WHAT IT IS USED FOR <br>
(trg)="51"> ŠTO JE WILZIN I ZA ŠTO SE KORISTI <br>
<hr>
(src)="51"> For a full list of excipients , see section 6.1 . <br>
(trg)="52"> Za cjeloviti popis pomoćnih tvari , vidjeti dio 6.1 . <br>
<hr>
(src)="52"> Hard capsule . <br>
(trg)="53"> Tvrda kapsula . <br>
<hr>
(src)="53"> Do not take Wilzin If you are allergic ( hypersensitive ) to zinc or any of the other ingredients of Wilzin . <br>
(trg)="54"> Nemojte uzimati Wilzin Ako ste alergični ( preosjetljivi ) na cink ili na bilo koji drugi sastojak lijeka Wilzin . <br>
<hr>
(src)="54"> SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN <br>
(trg)="55"> POSEBNO UPOZORENJE DA LIJEK TREBA ČUVATI IZVAN DOHVATA I POGLEDA DJECE <br>
<hr>
(src)="55"> Taking Wilzin with food and drink <br>
(trg)="56"> Uzimanje hrane i pića s Wilzinom <br>
<hr>
(src)="56"> UNIQUE IDENTIFIER - HUMAN READABLE DATA <br>
(trg)="57"> JEDINSTVENI IDENTIFIKATOR - PODACI ČITLJIVI LJUDSKIM OKOM <br>
<hr>
(src)="57"> In this case , you must inform your doctor . <br>
(trg)="58"> U ovom slučaju , morate obavijestiti svog liječnika . <br>
<hr>
(src)="58"> 6.5 Nature and contents of container <br>
(trg)="59"> 6.5 Vrsta i sadržaj spremnika <br>
<hr>
(src)="59"> Wilzin should be taken on an empty stomach , separated from mealtimes . <br>
(trg)="60"> Wilzin treba uzimati na prazan želudac , odvojeno od obroka . <br>
<hr>
(src)="60"> It is extremely important that pregnant Wilson 's disease patients continue their therapy during pregnancy . <br>
(trg)="61"> Iznimno je važno da trudnice s Wilsonovom bolesti nastave svoje liječenje tijekom trudnoće . <br>
<hr>
(src)="61"> Belgique / België / Belgien Recordati <br>
(trg)="62"> België / Belgique / Belgien Recordati <br>
<hr>
(src)="62"> If you take more Wilzin than prescribed , you may experience nausea , vomiting and dizziness . <br>
(trg)="63"> Ako uzmete više Wilzina nego što Vam je propisano , možete osjetiti mučninu , vrtoglavicu ili povraćati . <br>
<hr>
(src)="63"> Monitoring may detect evidence of insufficient treatment ( copper excess ) or excessive treatment ( copper deficiency ) , both of which can be harmful , particularly to growing children and pregnant women . <br>
(trg)="64"> Praćenje može otkriti dokaze nedovoljnog liječenja ( višak bakra ) ili pretjeranog liječenja ( manjak bakra ) , od kojih oba mogu biti štetna , pogotovo za djecu koja rastu i trudnice . <br>
<hr>
(src)="64"> • Changes in blood tests have been reported , including an increase in some liver and pancreatic enzymes . <br>
(trg)="65"> • Zabilježene su promjene u krvnim pretragama , uključujući porast nekih enzima jetre i gušterače . <br>
<hr>
(src)="65"> The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates ( EURD list ) provided for under Article 107c ( 7 ) of Directive 2001 / 83 / EC and any subsequent updates published on the European medicines webportal . <br>
(trg)="66"> Zahtjevi za podnošenje periodičkih izvješća o neškodljivosti za ovaj lijek definirani su u referentnom popisu datuma EU ( EURD popis ) predviđenom člankom 107 . c stavkom 7 . <br>
(trg)="67"> Direktive 2001 / 83 / EZ i svim sljedećim ažuriranim verzijama objavljenima na europskom internetskom portalu za lijekove . <br>
<hr>
(src)="66"> Do not store above 25 ° C. <br>
(trg)="68"> Nemojte čuvati na temperaturi iznad 25 ° C . <br>
<hr>
(src)="67"> Date of first authorisation : 13 October 2004 <br>
(trg)="69"> Datum prvog odobrenja : 13 . listopad 2004 . <br>
<hr>
(src)="68"> 2D barcode carrying the unique identifier included . <br>
(trg)="70"> Sadrži 2D barkod s jedinstvenim identifikatorom . <br>
<hr>
(src)="69"> In the blood , about 80 % of absorbed zinc is distributed to erythrocytes , with most of the remainder being bound to albumin and other plasma proteins . <br>
(trg)="71"> U krvi se oko 80 % apsorbiranog cinka raspoređuje u eritrocite , dok se većina preostalog cinka nalazi vezana za albumin i druge proteine plazme . <br>
<hr>
(src)="70"> Food <br>
(trg)="72"> Hrana <br>
<hr>
(src)="71"> This potentially leads to liver damage and neurological disorders . <br>
(trg)="73"> Ovo može dovesti do oštećenja jetre i neuroloških poremećaja . <br>
<hr>
(src)="72"> Heavy metal chelation therapy should be considered if plasma zinc levels are markedly elevated ( &gt; 10 mg / l ) . <br>
(trg)="74"> Kelirajuću terapiju teškim metalima treba razmotriti ako je razina cinka u plazmi značajno povišena ( &gt; 10 mg / l ) . <br>
<hr>
(src)="73"> A dose of 25 mg 3 times daily is usually effective but the dose should be adjusted to copper levels ( see section 4.4 and section 4.6 ) . <br>
(trg)="75"> Doza od 25 mg 3 puta dnevno je obično učinkovita , ali dozu treba prilagoditi prema razini bakra ( vidjeti dio 4.4 i dio 4.6 ) . <br>
<hr>
(src)="74"> It is available in packs of 250 hard capsules in a polyethylene bottle closed by a polypropylene and polyethylene closure . <br>
(trg)="76"> Dostupan je u pakovanjima od 250 tvrdih kapsula u polietilenskoj bočici zatvorenoj polipropilenskim i polietilenskim zatvaračem . <br>
<hr>
(src)="75"> • Do not store above 25 ° C. <br>
(trg)="77"> • Nemojte čuvati na temperaturi iznad 25 ° C . <br>
<hr>
(src)="76"> Anaemia may be micro- , normo- or macrocytic and is often associated with leukopenia . <br>
(trg)="78"> Anemija može biti mikro - , normo - ili makrocitna te je često povezana s leukopenijom . <br>
<hr>
(src)="77"> The plasma elimination half-life of zinc in healthy subjects is around 1 hour after a dose of 45 mg . <br>
(trg)="79"> Poluvrijeme eliminacije cinka iz plazme kod zdravih ispitanika iznosi oko 1 sat nakon doze od 45 mg . <br>
<hr>
(src)="78"> 4.1 Therapeutic indications <br>
(trg)="80"> 4.1 Terapijske indikacije <br>
<hr>
(src)="79"> These side effects may occur with certain frequencies , which are defined as follows : • very common : <br>
(trg)="81"> Ove nuspojave mogu se dogoditi s određenom učestalošću , koja je definirana na sljedeći način : <br>
<hr>
(src)="80"> Whether this is related to mobilisation of copper stores or to natural history of the disease remains unclear . <br>
(trg)="82"> Ostaje nejasno da li je to povezano s mobilizacijom zaliha bakra ili prirodnim tijekom bolesti . <br>
<hr>
(src)="81"> Please discuss with your doctor . <br>
(trg)="83"> Molimo , razgovarajte o tome sa svojim liječnikom . <br>
<hr>
(src)="82"> In order to follow up your condition and treatment your doctor will check your blood and urine on a regular basis . <br>
(trg)="84"> Vaš će liječnik redovito kontrolirati Vašu krv i mokraću . <br>
<hr>
(src)="83"> • Adults : <br>
(trg)="85"> • Odrasli : <br>
<hr>
(src)="84"> Five miscarriages and 2 birth defects ( microcephaly and correctable heart defect ) were reported in 42 pregnancies . <br>
(trg)="86"> Pet spontanih pobačaja i 2 malformacije ( mikrocefalija i srčana greška koja se mogla ispraviti ) zabilježeno je na 42 trudnoće . <br>
<hr>
(src)="85"> Pharmacological and toxicological data available showed large similarities between zinc salts and among animal species . <br>
(trg)="87"> Dostupni farmakološki i toksikološki podaci pokazali su velike sličnosti među cinkovim solima i među životinjskim vrstama . <br>
<hr>
(src)="86"> However , they must be distinguished from haemolytic anaemia which commonly occurs where there is elevated serum free copper in uncontrolled Wilson 's disease . <br>
(trg)="88"> Međutim , moraju se razlikovati od hemolitičke anemije do koje često dolazi kada je povišen slobodni bakar u serumu kod nekontrolirane Wilsonove bolesti . <br>
<hr>
(src)="87"> 4.3 Contraindications <br>
(trg)="89"> 4.3 Kontraindikacije <br>
<hr>
(src)="88"> Wilzin treatment should be initiated under the supervision of a physician experienced in the treatment of Wilson 's disease ( see section 4.4 ) . <br>
(trg)="90"> Liječenje Wilzinom treba započeti pod nadzorom liječnika s iskustvom u liječenju Wilsonove bolesti ( vidjeti dio 4.4 ) . <br>
<hr>
(src)="89"> What Wilzin contains <br>
(trg)="91"> Što Wilzin sadrži <br>
<hr>
(src)="90"> It ranges from 30 to 60 % with usual dietary intake ( 7-15 mg / d ) and decreases to 7 % with pharmacological doses of 100 mg / d . <br>
(trg)="92"> Nalazi se u rasponu od 30 do 60 % kod uobičajenog unosa putem prehrane ( 7 - 15 mg / d ) i smanjuje se na 7 % pri farmakološkim dozama od 100 mg / d . <br>
<hr>
(src)="91"> Dietary copper , which cannot be properly eliminated , accumulates first in the liver , then in other organs such as the eyes and the brain . <br>
(trg)="93"> Bakar iz hrane , koji se ne može pravilno izlučiti , nakuplja se prvo u jetri , a zatim u drugim organima poput očiju i mozga . <br>
<hr>
(src)="92"> • After Wilzin intake , gastric irritation may occur , especially at the beginning of treatment . <br>
(trg)="94"> • Nakon uzimanja Wilzina , može doći do nadražaja želuca , osobito na početku liječenja . <br>
<hr>
(src)="93"> frequency cannot be estimated from the available data . <br>
(trg)="95"> • nepoznato : učestalost se ne može odrediti iz dostupnih podataka . <br>
<hr>
(src)="94"> Blood and lymphatic system disorders uncommon : sideroblastic anaemia , leukopenia <br>
(trg)="96"> Poremećaji krvi i limfnog sustava manje često : sideroblastična anemija , leukopenija <br>
<hr>
(src)="95"> In this leaflet : <br>
(trg)="97"> U ovoj uputi : <br>
<hr>
(src)="96"> The non-ceruloplasmin plasma copper is calculated by subtracting the ceruloplasmin-bound copper from the total plasma copper , given that each milligram of ceruloplasmin contains 3 micrograms of copper . <br>
(trg)="98"> Ne - ceruloplazminski bakar u plazmi računa se tako da se od ukupnog bakra u plazmi oduzme bakar vezan za ceruloplazmin , računajući da svaki miligram ceruloplazmina sadrži 3 mikrograma bakra . <br>
<hr>
(src)="97"> Please consult your doctor before taking any other medicines which may reduce the effectiveness of Wilzin , such as iron , calcium supplements , tetracyclines ( antibiotics ) or phosphorus . <br>
(trg)="99"> Molimo Vas da se posavjetujete sa svojim liječnikom prije uzimanja bilo kojih drugih lijekova koji mogu smanjiti učinkovitost Wilzina , poput željeza , dodatka kalcija , tetraciklina ( antibiotika ) ili fosfora . <br>
<hr>
(src)="98"> Patients may present clinically with predominantly hepatic , neurologic , or psychiatric symptoms . <br>
(trg)="100"> Bolesnici se mogu klinički očitovati pretežno jetrenim , neurološkim ili psihijatrijskim simptomima . <br>
<hr>
(src)="99"> Bone marrow examination usually reveals characteristic " ringed sideroblasts " ( i.e. developing red blood cells containing iron-engorged paranuclear mitochondria ) . <br>
(trg)="101"> Pregled koštane srži obično pokazuje karakteristične " prstenaste sideroblaste " ( tj . crvene krvne stanice u razvoju koje sadrže paranuklearne mitohondrije prepunjene željezom ) . <br>
<hr>
(src)="100"> Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V. <br>
(trg)="102"> Od zdravstvenih radnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava : navedenog u Dodatku V . <br>
<hr>
</body>
</html>
